All updated as on -
The market for DNA synthesizers is anticipated to grow from US$ 5.30 billion in 2023 to US$ 15.69 billion in 2030, at a CAGR of 21.2% over the forecast period of 2023–2030.
The market is expected to grow at a promising rate over the forecast period, which is attributed to expanding gene synthesis-related research and development as well as ongoing advancements in technological processes like molecular separation and protein purification technology, which aid in the creation of dependable, efficient, and cost-effective solutions. The increase in the use of DNA synthesis in medical, diagnostic, academic, and industrial research will fuel market growth throughout the anticipated time period.
The natural process of DNA synthesis is DNA replication. However, in labs, DNA is artificially created using genetic engineering and enzyme chemistry. This deoxyribonucleotide is used in genetic engineering, diagnostics, therapeutic applications, as well as in academic and commercial research. Fundamental factors that confirm the quality of synthesis from different firms are cost per base pair, error rates, lengths, and throughput. The DNA synthesis market is being driven by the growing use of DNA synthesis across multiple end-use industries, including synthetic biology, immunology, cancer research, food science, immunology, antibody development, agriculture, and food science. As a result, it is anticipated that throughout the predicted period, demand for DNA synthesis will rise quickly.
High-throughput DNA synthesizers are becoming increasingly necessary so that scientists can quickly produce vast numbers of unique DNA sequences. Applications such as DNA-based library screening for drug discovery, large-scale gene assembly, and library preparation for next-generation sequencing are all made possible by high-throughput synthesis. To address this need, DNA synthesizer producers are concentrating on enhancing synthesis speed and scalability. DNA synthesizers are increasingly becoming portable and miniaturized. Compact and portable DNA synthesizers include benefits like more flexibility, the ability to perform synthesis on demand, and field-based applications. These mobile devices are especially helpful in resource-constrained environments, field research, and point-of-care diagnostics, when access to a fully functional laboratory may be limited.
DNA synthesizers are being equipped with automation and robotics technology to improve productivity. Automated systems are capable of carrying out operations including reagent dispensing, mixing, and purification, which minimizes manual work and human error. DNA synthesizers are useful for large-scale research and industrial applications because they can do high-throughput synthesis and have improved repeatability because to their integration with robotic platforms. To increase the effectiveness and precision of DNA synthesis, DNA synthesizers are using cutting-edge synthesis techniques. In contrast to conventional chemical approaches, enzyme-based synthesis has advantages including better fidelity and the capacity to integrate changed nucleotides. Using light to initiate nucleotide coupling in photochemical synthesis, the synthesis process can be precisely controlled. In the market for DNA synthesizers, these cutting-edge synthesis techniques are becoming more popular.
Viral and bacterial infections are spreading swiftly due to the rise in the prevalence of infectious diseases worldwide. Therefore, there is a larger need for cutting-edge therapies to properly combat such deadly diseases. Chemical drugs and biological therapies such as gene therapy are also effective ways to treat certain diseases. Through genomics, the treatment of infectious and endemic diseases has improved. It also helps us to evaluate rising drug resistance and identify potential vaccination and therapy targets.
The COVID-19 pandemic outbreak has had an effect on all industries and has resulted in a number of unexpected changes to the world economy. The enabling government law is one of the primary market drivers for synthetic biology. Recently, investors' attention has shifted to synthetic biology due to the growing demand for the sector. By 2020, governmental and private funding sources will have invested roughly USD 8 billion in the field of synthetic biology.
Report Coverage
Global DNA Synthesizer research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global DNA Synthesizer report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and DNA Synthesizer competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key DNA Synthesizer market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global DNA Synthesizer market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, DNA Synthesizer market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Danaher Corporation (Integrated DNA Technologies), GenScript Biotech Corporation, Eurofins Genomics, LGC Limited, BioAutomation Corporation, Bio-Rad Laboratories, Twist Bioscience Corporation, Hamilton Company, Expedeon AG, New England Biolabs, Nippon Genetics, LGC Biosearch Technologies, GE Healthcare Life Sciences, Polygen GmbH, GlobalSpec, Renesas Electronics Corporation, Applied Biosystems, K & A Laborgerte, Gene Synthesis, Beckman Coulter, Synthomics, Inc., ACTGene, Silicycle, Argonaut Technologies, Personal Chemistry, Electrothermal, Tekna Plasma Systems Inc, Biolytic Lab Performance Inc., Protein Technologies Overture, Precision System Science Co., Ltd.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global DNA Synthesizer market based on the below-mentioned segments:
Global DNA Synthesizer Market, By Type
Benchtop DNA Synthesizers
Industrial DNA Synthesizers
Portable DNA Synthesizers
Global DNA Synthesizer market, By Application
Gene Synthesis
Oligonucleotide Synthesis
Next-Generation Sequencing (NGS) Library Preparation
Drug Development
Others (DNA labeling, aptamer synthesis, synthetic biology)
Global DNA Synthesizer Market, By End User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Contract Research Organizations (CROs)
Forensic Laboratories
Others (government organizations, diagnostic laboratories, agriculture companies)
Global DNA Synthesizer market, Regional Analysis
The market is expected to grow at a promising rate over the forecast period, which is attributed to expanding gene synthesis-related research and development as well as ongoing advancements in technological processes like molecular separation and protein purification technology, which aid in the creation of dependable, efficient, and cost-effective solutions. The increase in the use of DNA synthesis in medical, diagnostic, academic, and industrial research will fuel market growth throughout the anticipated time period.
The natural process of DNA synthesis is DNA replication. However, in labs, DNA is artificially created using genetic engineering and enzyme chemistry. This deoxyribonucleotide is used in genetic engineering, diagnostics, therapeutic applications, as well as in academic and commercial research. Fundamental factors that confirm the quality of synthesis from different firms are cost per base pair, error rates, lengths, and throughput. The DNA synthesis market is being driven by the growing use of DNA synthesis across multiple end-use industries, including synthetic biology, immunology, cancer research, food science, immunology, antibody development, agriculture, and food science. As a result, it is anticipated that throughout the predicted period, demand for DNA synthesis will rise quickly.
High-throughput DNA synthesizers are becoming increasingly necessary so that scientists can quickly produce vast numbers of unique DNA sequences. Applications such as DNA-based library screening for drug discovery, large-scale gene assembly, and library preparation for next-generation sequencing are all made possible by high-throughput synthesis. To address this need, DNA synthesizer producers are concentrating on enhancing synthesis speed and scalability. DNA synthesizers are increasingly becoming portable and miniaturized. Compact and portable DNA synthesizers include benefits like more flexibility, the ability to perform synthesis on demand, and field-based applications. These mobile devices are especially helpful in resource-constrained environments, field research, and point-of-care diagnostics, when access to a fully functional laboratory may be limited.
DNA synthesizers are being equipped with automation and robotics technology to improve productivity. Automated systems are capable of carrying out operations including reagent dispensing, mixing, and purification, which minimizes manual work and human error. DNA synthesizers are useful for large-scale research and industrial applications because they can do high-throughput synthesis and have improved repeatability because to their integration with robotic platforms. To increase the effectiveness and precision of DNA synthesis, DNA synthesizers are using cutting-edge synthesis techniques. In contrast to conventional chemical approaches, enzyme-based synthesis has advantages including better fidelity and the capacity to integrate changed nucleotides. Using light to initiate nucleotide coupling in photochemical synthesis, the synthesis process can be precisely controlled. In the market for DNA synthesizers, these cutting-edge synthesis techniques are becoming more popular.
Viral and bacterial infections are spreading swiftly due to the rise in the prevalence of infectious diseases worldwide. Therefore, there is a larger need for cutting-edge therapies to properly combat such deadly diseases. Chemical drugs and biological therapies such as gene therapy are also effective ways to treat certain diseases. Through genomics, the treatment of infectious and endemic diseases has improved. It also helps us to evaluate rising drug resistance and identify potential vaccination and therapy targets.
The COVID-19 pandemic outbreak has had an effect on all industries and has resulted in a number of unexpected changes to the world economy. The enabling government law is one of the primary market drivers for synthetic biology. Recently, investors' attention has shifted to synthetic biology due to the growing demand for the sector. By 2020, governmental and private funding sources will have invested roughly USD 8 billion in the field of synthetic biology.
Report Coverage
Global DNA Synthesizer research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global DNA Synthesizer report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and DNA Synthesizer competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key DNA Synthesizer market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Danaher Corporation (Integrated DNA Technologies), GenScript Biotech Corporation, Eurofins Genomics, LGC Limited, BioAutomation Corporation, Bio-Rad Laboratories, Twist Bioscience Corporation, Hamilton Company, Expedeon AG, New England Biolabs, Nippon Genetics, LGC Biosearch Technologies, GE Healthcare Life Sciences, Polygen GmbH, GlobalSpec, Renesas Electronics Corporation, Applied Biosystems, K & A Laborgerte, Gene Synthesis, Beckman Coulter, Synthomics, Inc., ACTGene, Silicycle, Argonaut Technologies, Personal Chemistry, Electrothermal, Tekna Plasma Systems Inc, Biolytic Lab Performance Inc., Protein Technologies Overture, Precision System Science Co., Ltd. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of DNA Synthesizer Market from 2021 to 2030.
- Market Forecast for DNA Synthesizer Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, DNA Synthesizer competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on DNA Synthesizer
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global DNA Synthesizer market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, DNA Synthesizer market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Danaher Corporation (Integrated DNA Technologies), GenScript Biotech Corporation, Eurofins Genomics, LGC Limited, BioAutomation Corporation, Bio-Rad Laboratories, Twist Bioscience Corporation, Hamilton Company, Expedeon AG, New England Biolabs, Nippon Genetics, LGC Biosearch Technologies, GE Healthcare Life Sciences, Polygen GmbH, GlobalSpec, Renesas Electronics Corporation, Applied Biosystems, K & A Laborgerte, Gene Synthesis, Beckman Coulter, Synthomics, Inc., ACTGene, Silicycle, Argonaut Technologies, Personal Chemistry, Electrothermal, Tekna Plasma Systems Inc, Biolytic Lab Performance Inc., Protein Technologies Overture, Precision System Science Co., Ltd.
Primary Target Market
- Market Players of DNA Synthesizer
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global DNA Synthesizer market based on the below-mentioned segments:
Global DNA Synthesizer Market, By Type
Benchtop DNA Synthesizers
Industrial DNA Synthesizers
Portable DNA Synthesizers
Global DNA Synthesizer market, By Application
Gene Synthesis
Oligonucleotide Synthesis
Next-Generation Sequencing (NGS) Library Preparation
Drug Development
Others (DNA labeling, aptamer synthesis, synthetic biology)
Global DNA Synthesizer Market, By End User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Contract Research Organizations (CROs)
Forensic Laboratories
Others (government organizations, diagnostic laboratories, agriculture companies)
Global DNA Synthesizer market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive dna synthesizer market market research and competitor analysis for your business to help you develop more profound insights into the dna synthesizer market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the dna synthesizer market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.